ANI Pharma appoints Henry Gosebruch to board of directors - ANIP News | RalliesANI Pharma appoints Henry Gosebruch to board of directors
A
ANIP• Board appointment and resignation
- ANI Pharmaceuticals appointed Henry Gosebruch to its board, effective Aug. 19, 2026.
- Gosebruch has been CEO of Lakefront Biotherapeutics NV since May 2025.
- He previously served as CEO of Neumora Therapeutics from July 2023 to February 2025.
- Earlier roles include AbbVie executive vice president and chief strategy officer from 2015 to 2023, leading corporate strategy and M&A.
- Director Muthusamy Shanmugam resigned from the board, effective immediately.
•
